In conclusion, in this two stage discovery-validation study, we highlighted two potential functional locus, GAS5 rs2067079 and rs6790 for chemoradiotherapy induced severe myelosuppression and severe neutropenia among NPC patients for the first time. The gene discussed is GAS5; the disease is Decreased total neutrophil count.